Cue helps users track their health at the molecular level, revealing the interplay of activity, food & sleep.
Latest Company Updates
Industry Coverage
Google’s provider of at-home Covid-19 tests is now a $3 billion company traded on Nasdaq
Read More >>
Covid Test Startup Cue Health in Talks for $2 Billion-Plus Valuation
Read More >>
Cue Health CEO on new Covid-19 diagnostic test
Read More >>
Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics
Read More >>
Cue Health awarded $13 million government contract to develop portable, point-of-care COVID-19 test
Read More >>
Ready Responders land $48M to administer COVID-19 tests at home
Read More >>Cue Is Hiring
No Available Positions
View More Portfolio Companies
Select Another Portfolio Company